Tamoxifen resistance-related ceRNA network for breast cancer

Background: Tamoxifen (TMX) is one of the most widely used drugs to treat breast cancer (BC). However, acquired drug resistance is still a major obstacle to its application, rendering it crucial to explore the mechanisms of TMX resistance in BC. This aims of this study were to identify the mechanism...

Full description

Bibliographic Details
Main Authors: Zipeng Qiao, Yu Xing, Qingquan Zhang, Yongjun Tang, Ruifa Feng, Weiyi Pang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2022.1023079/full